Randomized Study for Effectiveness and Safety Evaluation of Dexamethasone 0.5 mg + Fumarate Clemastine 1 mg Compared to Dexamethasone 0.5 mg in Patients With Allergic Dermatitis

NCT01239719 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergy
Dermatitis

Interventions

DRUG: Dexamethasone + clemastine
DRUG: Dexamethasone

Sponsor

Azidus Brasil